These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1651161)

  • 101. [Physiology and pathophysiology of the metabolism of lipoproteins].
    Sandhofer F
    Wien Med Wochenschr; 1994; 144(12-13):286-90. PubMed ID: 8650930
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Current standards in diagnosis and therapy of hyperlipoproteinemia.
    Fischer S; Schatz U; Julius U
    Atheroscler Suppl; 2013 Jan; 14(1):15-8. PubMed ID: 23357135
    [TBL] [Abstract][Full Text] [Related]  

  • 103. [Recent pathophysiologic aspects of atherogenesis].
    Kostner G
    Wien Med Wochenschr; 1990 Feb; 140(4):101-9. PubMed ID: 2158191
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Dyslipoproteinemias in atherosclerosis, thrombosis and restenosis after coronary angioplasty.
    Myler RK; Ryan C; Dunlap R; Shaw RE; Bashour TT; Cumberland DC; Mooney MR
    J Invasive Cardiol; 1995 Mar; 7(2):33-46. PubMed ID: 10155712
    [TBL] [Abstract][Full Text] [Related]  

  • 105. [LP (a) lipoprotein: a new independent risk factor for atherogenesis].
    Davidoff P
    Rev Med Chil; 1991 Jan; 119(1):64-8. PubMed ID: 1840458
    [TBL] [Abstract][Full Text] [Related]  

  • 106. The role of lipoprotein receptors in lipid transport and in the pathogenesis of the hyperlipoproteinemias.
    Chait A
    Spec Top Endocrinol Metab; 1983; 5():1-53. PubMed ID: 6322371
    [TBL] [Abstract][Full Text] [Related]  

  • 107. [Nicotinic acid and derivatives for therapy of hyperlipoproteinemia].
    Ishikawa T
    Nihon Rinsho; 1994 Dec; 52(12):3292-7. PubMed ID: 7853725
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Lipoprotein(A): physiologic function, association with atherosclerosis, and effects of lipid-lowering drug therapy.
    Spinler SA; Cziraky MJ
    Ann Pharmacother; 1994 Mar; 28(3):343-51. PubMed ID: 8193425
    [TBL] [Abstract][Full Text] [Related]  

  • 109. [Lipoproteins and their metabolism].
    Rywik S; Broda G
    Kardiol Pol; 1992; 36(2):110-4. PubMed ID: 1583826
    [No Abstract]   [Full Text] [Related]  

  • 110. [Lipoprotein Lp(a): a new risk factor of atherogenesis].
    Davidoff P; Bruckert E; Giral P; Doumith R; Thervet F; Truffert J; de Gennes JL
    Diabete Metab; 1989; 15(2):55-60. PubMed ID: 2525490
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Recent developments in atherogenesis.
    Stein O; Stein Y
    Arzneimittelforschung; 1990 Mar; 40(3A):348-50. PubMed ID: 2185761
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Mechanisms of lipid-lowering agents.
    Sirtori CR; Manzoni C; Lovati MR
    Cardiology; 1991; 78(3):226-35. PubMed ID: 1868500
    [TBL] [Abstract][Full Text] [Related]  

  • 113. [Lipoprotein(a): risk factor for atherosclerotic vascular disease important to take into account in practice].
    Couderc R; Maachi M
    Ann Biol Clin (Paris); 1999; 57(2):157-67. PubMed ID: 10210742
    [TBL] [Abstract][Full Text] [Related]  

  • 114. [Gene polymorphisms in atherosclerotic diseases and lipoprotein metabolism disorders].
    Yokode M
    Nihon Ronen Igakkai Zasshi; 1999 Apr; 36(4):238-41. PubMed ID: 10410565
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a).
    Grützmacher P; Öhm B; Szymczak S; Dorbath C; Brzoska M; Kleinert C
    Clin Res Cardiol Suppl; 2017 Mar; 12(Suppl 1):22-26. PubMed ID: 28233269
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Hyperlipoproteinemia(a): clinical significance and treatment options.
    Berthold HK; Gouni-Berthold I
    Atheroscler Suppl; 2013 Jan; 14(1):1-5. PubMed ID: 23357133
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Apolipoproteins and atherosclerosis. Apolipoprotein E and apolipoprotein(a) as candidate genes of premature development of atherosclerosis.
    Horejsí B; Ceska R
    Physiol Res; 2000; 49 Suppl 1():S63-9. PubMed ID: 10984073
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Pathogenesis of atherosclerosis.
    Moore S
    Metabolism; 1985 Dec; 34(12 Suppl 1):13-6. PubMed ID: 3906356
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Hyperlipoproteinemia in chronic renal failure: pathophysiological and therapeutic aspects.
    Wanner C; Frommherz K; Hörl WH
    Cardiology; 1991; 78(3):202-17. PubMed ID: 1868498
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Lipoprotein(a): from molecules to therapeutics.
    Bermúdez V; Arráiz N; Aparicio D; Rojas E; Gotera D; Guerra X; Canelón R; Faría J; Sorell L; Amell A; Reyna N; Cabrera M; Mengual E; Cano R; Cano C; Velasco M
    Am J Ther; 2010; 17(3):263-73. PubMed ID: 20479580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.